Novo Nordisk A/S – Share repurchase programme
Bagsværd, Denmark, 26 August 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.
Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.
Since the announcement as of 19 August 2019, the following transactions have been made:
| Number of B shares | Average purchase price | Transaction value, DKK | |
| Accumulated, last announcement | 812,000 | 276,596,632 | |
| 19 August 2019 | 132,000 | 344.76 | 45,507,714 |
| 20 August 2019 | 125,000 | 346.85 | 43,355,680 |
| 21 August 2019 | 125,000 | 347.95 | 43,493,638 |
| 22 August 2019 | 125,000 | 353.30 | 44,162,189 |
| 23 August 2019 | 120,000 | 354.65 | 42,558,204 |
| Accumulated under the programme | 1,439,000 | 495,674,057 |
The details for each transaction made under the share repurchase programme are published on novonordisk.com.
With the transactions stated above, Novo Nordisk owns a total of 31,999,194 B shares of DKK 0.20, corresponding to 1.3% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.
Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 23 August 2019, Novo Nordisk has since 1 February 2019 repurchased a total of 24,840,012 B shares at an average share price of DKK 327.32 per B share equal to a transaction value of DKK 8,130,627,511.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
| Ken Inchausti (US) | +1 609 240 9429 | kiau@novonordisk.com |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
| Valdemar Borum Svarrer | +45 3079 0301 | jvls@novonordisk.com |
| Ann Søndermølle Rendbæk | +45 3075 2253 | arnd@novonordisk.com |
| Kristoffer Due Berg (US) | +1 609 235 2989 | krdb@novonordisk.com |
Company announcement no. 50 / 2019
Attachment
